These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9949259)

  • 41. [Medical treatment of gastroesophageal reflux by H2 receptor antagonists].
    Scarpignato C; Bruley des Varannes S
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S78-89. PubMed ID: 10078436
    [No Abstract]   [Full Text] [Related]  

  • 42. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
    Cohen S; Bueno de Mesquita M; Mimouni FB
    Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Second Canadian Gastroesophageal Reflux Disease Consensus: moving forward to new concepts.
    Thomson AB; Chiba N; Armstrong D; Tougas G; Hunt RH
    Can J Gastroenterol; 1998; 12(8):551-6. PubMed ID: 9926265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Gastroesophageal reflux disease in pregnancy].
    Nikolov A; Pevtichev S; Petrova D
    Akush Ginekol (Sofiia); 2013; 52(7):35-40. PubMed ID: 24505639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Heartburn: in short-term treatment you have the choice!].
    Camain JY; Wiesel PH; Peytremann-Bridevaux I
    Praxis (Bern 1994); 2012 Feb; 101(5):331-2. PubMed ID: 22377981
    [No Abstract]   [Full Text] [Related]  

  • 47. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates.
    Malcolm WF; Cotten CM
    Clin Perinatol; 2012 Mar; 39(1):99-109. PubMed ID: 22341540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical therapy for gastroesophageal reflux disease.
    Arora AS; Castell DO
    Mayo Clin Proc; 2001 Jan; 76(1):102-6. PubMed ID: 11155401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update on gastroesophageal reflux disease.
    Ledger S
    CANNT J; 2005; 15(4):44-7; quiz 48-9. PubMed ID: 16491998
    [No Abstract]   [Full Text] [Related]  

  • 50. Medical management vs. surgery for gastroesophageal reflux disease.
    Kripke C
    Am Fam Physician; 2010 Aug; 82(3):244. PubMed ID: 20672787
    [No Abstract]   [Full Text] [Related]  

  • 51. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
    van Zanten SV
    Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
    [No Abstract]   [Full Text] [Related]  

  • 52. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 53. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Maintenance therapy of mild form of GERD by H2 receptor antagonists].
    Kurosawa S
    Nihon Rinsho; 2000 Sep; 58(9):1859-64. PubMed ID: 11004816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and Treatment of Gastroesophageal Reflux in Infants and Children.
    Baird DC; Harker DJ; Karmes AS
    Am Fam Physician; 2015 Oct; 92(8):705-14. PubMed ID: 26554410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel pharmaceutical approaches to reflux disease.
    Dutta U; Armstrong D
    Gastroenterol Clin North Am; 2013 Mar; 42(1):93-117. PubMed ID: 23452633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms.
    Tougas G; Armstrong D
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():51B-54B. PubMed ID: 9347179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Individualized acute treatment strategies for gastroesophageal reflux disease.
    Reynolds JC
    Scand J Gastroenterol Suppl; 1995; 213():17-24. PubMed ID: 8578239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drugs, bugs, and esophageal pH profiles.
    Robinson M
    Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uses and abuses of acid-suppression therapy in children.
    Hassall E
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S8-9. PubMed ID: 22235449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.